← Eichor
Study identifier: NCT06333652 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Ravulizumab in Pregnancies Complicated by Severe Hypertensive Disorders

Condition: Preeclampsia  ·  Sponsor: Mayo Clinic

PhasePhase 2
Planned participants14
Who can joinFemale, 18 Years to 50 Years
Healthy volunteersNo

About this study

The researchers are testing a medication named ravulizumab for the treatment of severe preeclampsia and Hemolysis, Elevated Liver enzymes, Low Platelets (HELLP) syndrome.

This description comes directly from the study's public registry record.

Talk to the study team

Gonzalez Suarez  ·  507-284-2511

Always discuss trial participation with your own doctor first.

Locations (1)

Mayo Clinic MinnesotaRochester, Minnesota, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06333652